We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$73.4B
Turnover
30.34%
1-Year Est. Return
32.8%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+32.8%
3 Year Est. Return
+177.41%
5 Year Est. Return
+184.82%
10 Year Est. Return
+833.33%
AUM
$73.1B
AUM Growth
+$2.4B
(+3.4%)
Cap. Flow
-$1.43B
Cap. Flow % of AUM
Cap. Flow %
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,017
Closed
521
Avg Time Held
2.6
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.56% |
| 3 | Consumer Discretionary | 11.87% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Novo Nordisk
NVO
$184B
| $1.71B | 2.33% |
25,208,576
-5,409,166
| -18% | -$317M |
2013 Q2
38 quarters
|
|
|
2
Amazon
AMZN
$2.88T
| $953M | 1.3% |
11,347,000
+8,196,300
| +260% | +$810M |
2022 Q3
1 quarter
|
|
|
3
Apple
AAPL
$5.18T
| $922M | 1.26% |
7,099,648
+5,870,078
| +477% | +$839M |
2020 Q3
9 quarters
|
|
4
Gilead Sciences
GILD
$208B
| $790M | 1.08% |
9,202,568
-820,000
| -8% | -$64.9M |
2014 Q4
32 quarters
|
|
5
Airbnb
ABNB
$110B
| $736M | 1.01% |
8,602,746
+1,323,719
| +18% | +$134M |
2021 Q2
6 quarters
|
|
6
United Therapeutics
UTHR
$25.2B
| $652M | 0.89% |
2,344,492
-205,722
| -8% | -$51.9M |
2013 Q2
38 quarters
|
|
7
Vertex Pharmaceuticals
VRTX
$137B
| $649M | 0.89% |
2,246,752
+107,867
| +5% | +$32.9M |
2017 Q1
23 quarters
|
|
8
VeriSign
VRSN
$28.1B
| $634M | 0.87% |
3,085,390
-407,500
| -12% | -$78.1M |
2013 Q2
38 quarters
|
|
9
Hershey
HSY
$35B
| $617M | 0.84% |
2,665,167
-375,500
| -12% | -$86.6M |
2013 Q2
38 quarters
|
|
|
10
TSMC
TSM
$2.07T
| $564M | 0.77% |
7,577,020
+7,550,320
| +28,278% | +$546M |
2022 Q2
2 quarters
|
|
11
Franco-Nevada
FNV
$47.7B
| $494M | 0.68% |
3,622,803
-577,900
| -14% | -$76.3M |
2014 Q1
35 quarters
|
|
12
Kroger
KR
$41.8B
| $492M | 0.67% |
11,040,254
-1,885,456
| -15% | -$86.6M |
2019 Q2
14 quarters
|
|
13
Zoom
ZM
$29.1B
| $476M | 0.65% |
7,019,715
-780,689
| -10% | -$59.3M |
2020 Q1
11 quarters
|
|
14
Visa
V
$794B
| $468M | 0.64% |
2,253,074
+697,474
| +45% | +$141M |
2020 Q3
9 quarters
|
|
15
Advanced Micro Devices
AMD
$876B
| $447M | 0.61% |
6,905,890
-3,163,967
| -31% | -$209M |
2022 Q1
3 quarters
|
|
16
Molina Healthcare
MOH
$10.9B
| $430M | 0.59% |
1,302,437
-160,978
| -11% | -$54.7M |
2013 Q2
38 quarters
|
|
17
Amgen
AMGN
$252B
| $422M | 0.58% |
1,607,245
+974,000
| +154% | +$261M |
2021 Q3
5 quarters
|
|
|
18
Tesla
TSLA
$1.54T
| $419M | 0.57% |
3,405,017
+3,403,617
| +243,116% | +$644M |
2018 Q4
16 quarters
|
|
|
19
Johnson & Johnson
JNJ
$688B
| $398M | 0.54% |
+2,254,125
| New | +$389M |
2022 Q4
0 quarters
|
|
20
ExxonMobil
XOM
$696B
| $389M | 0.53% |
3,527,457
-967,397
| -22% | -$104M |
2021 Q1
7 quarters
|
|
21
Alphabet (Google) Class A
GOOGL
$3.64T
| $372M | 0.51% |
4,218,455
-990,005
| -19% | -$94.1M |
2022 Q3
1 quarter
|
|
22
Incyte
INCY
$24.7B
| $367M | 0.5% |
4,568,233
-279,000
| -6% | -$21.3M |
2017 Q4
20 quarters
|
|
23
Delta Air Lines
DAL
$56.7B
| $325M | 0.44% |
9,893,400
+1,077,500
| +12% | +$35.7M |
2021 Q3
5 quarters
|
|
24
PayPal
PYPL
$49.2B
| $320M | 0.44% |
+4,489,078
| New | +$359M |
2022 Q4
0 quarters
|
|
25
Keurig Dr Pepper
KDP
$49.5B
| $315M | 0.43% |
8,826,970
+3,253,909
| +58% | +$122M |
2019 Q2
14 quarters
|
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,017 reduced and 521 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 521 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.